Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. med. Schütze is an Austrian healthcare company specializing in innovative dental care and oral health solutions. Founded over 30 years ago, the company focuses on the oral microbiome and biologically holistic concepts for periodontitis therapy and gum health. Its flagship products, such as the PAROMiT Q10 spray, utilize Coenzyme Q10 and natural ingredients to support the oral immune system and maintain microbial balance. In 2021, the company was acquired by Institut AllergoSan, a prominent center for probiotic research, to integrate oral health into a broader microbiome-focused portfolio. Dr. med. Schütze continues to provide scientifically backed products to dentists and patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. med. Schütze.